BioCryst Pharmaceuticals, Inc. (BCRX) Reports In-Line Q4 EPS

Go back to BioCryst Pharmaceuticals, Inc. (BCRX) Reports In-Line Q4 EPS
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 9.93 +0.23 (2.37%)
Previous Close $9.70    52 Week High $10.98 
Open $9.93    52 Week Low $1.63 
Day High $10.01    P/E N/A 
Day Low $9.79    EPS $-0.68 
Volume 360,547